These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7682729)

  • 21. Development and in vitro evaluation of a controlled release formulation to produce wide dose interval morphine tablets.
    Holgado MA; Iruin A; Alvarez-Fuentes J; Fernández-Arévalo M
    Eur J Pharm Biopharm; 2008 Oct; 70(2):544-9. PubMed ID: 18588973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of intravenous abuse of oral morphine sulfate.
    Welch JS
    Am Fam Physician; 1997 Oct; 56(5):1307-8. PubMed ID: 9381990
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of morphine slow release tablet (MST) and morphine sulphate solution (MSS) in the treatment of cancer pain.
    Panich A; Charnvej L
    J Med Assoc Thai; 1993 Dec; 76(12):672-6. PubMed ID: 7798818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oramorph--two liquid morphine formulations.
    Drug Ther Bull; 1989 Sep; 27(18):71-2. PubMed ID: 2485097
    [No Abstract]   [Full Text] [Related]  

  • 25. Comment: dyspnea with controlled-release morphine sulfate tablets.
    Goldenheim PD
    Drug Intell Clin Pharm; 1988 Dec; 22(12):1005-6. PubMed ID: 3243171
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
    Dohoo SE; Tasker RA
    Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine in slow-release tablets.
    Drug Ther Bull; 1981 May; 19(11):44. PubMed ID: 7249942
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravaginal morphine: an alternative route of administration.
    Ostrop NJ; Lamb J; Reid G
    Pharmacotherapy; 1998; 18(4):863-5. PubMed ID: 9692663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Parenteral opioids in end-of-life care in cancer patients].
    Hattori S; Kimura N; Takatani J; Noguchi T
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):161-6. PubMed ID: 15751626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled release morphine tablets.
    Lancet; 1981 Apr; 1(8225):892. PubMed ID: 6112311
    [No Abstract]   [Full Text] [Related]  

  • 32. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer.
    Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA
    J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analgesic efficacy and safety of two oral controlled-release morphine preparations in orthopedic postoperative pain.
    Cooper SA; Fitzmartin R; Slywka J; Buckley BJ; Kaiko R; Goldenheim PD; Mooar P; Witte JF; Hersh EV
    Adv Ther; 1994; 11(5):213-27. PubMed ID: 10150266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosage range study of morphine sulfate controlled-release.
    Homesley HD; Welander CE; Muss HB; Richards F
    Am J Clin Oncol; 1986 Oct; 9(5):449-53. PubMed ID: 2430448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain management in palliative care. Morphine and the 'new' opioids in 2000.
    Virik K; Glare P
    Aust Fam Physician; 2000 Dec; 29(12):1167-71. PubMed ID: 11140226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of preoperative oral sustained-release morphine sulfate on postoperative morphine requirements in elective spine surgery.
    Bellissant E; Estèbe JP; Sébille V; Ecoffey C
    Fundam Clin Pharmacol; 2004 Dec; 18(6):709-14. PubMed ID: 15548244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral oxycodone: new preparation. No better than oral morphine.
    Prescrire Int; 2003 Jun; 12(65):83-4. PubMed ID: 12825566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effervescent morphine results in faster relief of breakthrough pain in patients compared to immediate release morphine sulfate tablet.
    Freye E; Levy JV; Braun D
    Pain Pract; 2007 Dec; 7(4):324-31. PubMed ID: 17986159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy.
    Davis MP; Varga J; Dickerson D; Walsh D; LeGrand SB; Lagman R
    Support Care Cancer; 2003 Feb; 11(2):84-92. PubMed ID: 12560936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of oral treatment with sustained release morphine tablets on hypothalamic-pituitary-adrenal axis.
    Palm S; Moenig H; Maier C
    Methods Find Exp Clin Pharmacol; 1997 May; 19(4):269-73. PubMed ID: 9228653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.